1Gajewski. B7-1 but not B7-2 efficiently costimulates CD8 + Tlymphocytes in the P815 tumor system in vitro[J].J Immunol. 1996,156(2):465-72.
2Jung D,Hilmes C,Knuth A,et al. Gene transfer of the Co-stimulatory molecules BT-1 and B7-2 enhances the immunogenicity of human renal cell carcinoma to a different extent[J]. Scand J Immunol. 1999,50(3) :242-9
3Guinn BA, DeBenedette MA, Wattas TH, et al. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell lineinto a long-lasting antitumor vaccine[J].J Immunol. 1999, 162(8):5003-10.
4Tatsumi T,Takehara T,Katayama K,et al. Expression of costimulatory molecules B7-1(CD80) and B7-2(CD86) on human hepatocellular carcinoma[J]. Hepatology. 1997,25 ( 5 ):1108 - 14.
5Hatheoek KS, Laszlo G, Pueillo C, et al, Comparative analysis of B7-1 and B7-2 eostimulatory ligands:expression and funetion[J].J Exp Med, 1994,180(2):631-40.
6Comer RM,King WJ,Ardjomand N,et al. Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival[J]. Invest Ophthalmol Vis Sci. 2002,43(4):1095-03.
10Chang TT,Kuchroo VK,Sharpe AH.The B7 family of ligands its receptors:new pathways for costimulation and inhibition of immune response.Curr Dir Autoimmun,2002,5:113-130.
